BCG Bacille Calmette Guerin CD cluster of differentiation
EcN Escherichia coli Nissle 1917 E.coli Escherichia coli
FGF2 fibroblast growth factor 2
g gram
Gfp green fluorescent protein
h hour
HER2 human epidermal growth factor 2
MOI multiplicity of infection
Appendix 102 MRI magnetic resonance imaging
NET neutrophil extracellular trap OD optical density
PAMP pathogen associated pattern PAS Periodic Acid Schiff PBS phosphate buffered saline PCR polymerase chain reaction PDGF platelet-derived growth
REM raster electron microscopy RNA ribonucleic acid
ROS reactive oxygen species RT-PCR reverse transcriptase
polymerase chain reaction
SCV Salmonella containing vacuole
SDM standard deviation of the mean
TGFβ transforming growth factorβ TLR toll-like receptor
TNF tumor necrosis factor TRAIL TNF-related
apoptosis-inducing ligand
TTSS type three secretion system
v volume
VEGF vascular endothelial growth factor
WT wildtype
Appendix 104 Beamer, B., Hettrich, C., and Lane, J. (2010). Vascular endothelial growth factor: an
essential component of angiogenesis and fracture healing. HSS Journal 6, 85-94.
Benoit, M.R., Mayer, D., Barak, Y., Chen, I.Y., Hu, W., Cheng, Z., Wang, S.X., Spielman, D.M., Gambhir, S.S., and Matin, A. (2009). Visualizing implanted tumors in mice with magnetic resonance imaging using magnetotactic bacteria. Clinical Cancer Research 15, 5170.
Bentzen, S.M. (2006). Preventing or reducing late side effects of radiation therapy:
radiobiology meets molecular pathology. Nature Reviews Cancer 6, 702-713.
Berg, H.C. (2003). The rotary motor of bacterial flagella. Biochemistry 72, 19.
Bernier, J., Hall, E.J., and Giaccia, A. (2004). Radiation oncology: a century of achievements. Nature Reviews Cancer 4, 737-747.
Bettegowda, C., Dang, L.H., Abrams, R., Huso, D.L., Dillehay, L., Cheong, I., Agrawal, N., Borzillary, S., McCaffery, J.M., and Watson, E. (2003). Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria. Proceedings of the National Academy of Sciences of the United States of America 100, 15083.
Blasberg, R. (2002). Imaging Gene Expression and Endogenous Molecular Processes:
Molecular Imaging. Journal of Cerebral Blood Flow & Metabolism 22, 1157-1164.
Boddicker, J.D., Ledeboer, N.A., Jagnow, J., Jones, B.D., and Clegg, S. (2002).
Differential binding to and biofilm formation on, HEp 2 cells by Salmonella enterica Serovar Typhimurium is dependent upon allelic variation in the fimH gene of the fim gene cluster.
Molecular microbiology 45, 1255-1265.
Brader, P., Stritzker, J., Riedl, C.C., Zanzonico, P., Cai, S., Burnazi, E.M., Ghani, E.R., Hricak, H., Szalay, A.A., and Fong, Y. (2008). Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging. Clinical Cancer Research 14, 2295.
Bray, D., Levin, M.D., and Lipkow, K. (2007). The chemotactic behavior of computer-based surrogate bacteria. Current biology 17, 12-19.
Brunelle, J.K. and Letai, A. (2009). Control of mitochondrial apoptosis by the Bcl-2 family.
Journal of cell science 122, 437.
Bucci, M.K., Bevan, A., and Roach III, M. (2005). Advances in radiation therapy:
conventional to 3D, to IMRT, to 4D, and beyond. CA: A Cancer Journal for Clinicians 55, 117-134.
Caldwell, J.C. (2001). Population health in transition. Bull. World Health Organ 79, 159-160.
Appendix 105 Chabner, B.A. and Roberts Jr, T.G. (2005). Timeline: Chemotherapy and the war on
cancer. Nature Reviews. Cancer 5, 65.
Chang, M.H., You, S.L., Chen, C.J., Liu, C.J., Lee, C.M., Lin, S.M., Chu, H.C., Wu, T.C., Yang, S.S., and Kuo, H.S. (2009). Decreased incidence of hepatocellular carcinoma in hepatitis B vaccines: a 20-year follow-up study. Journal of the National Cancer Institute 101, 1348.
Cheng, C.M., Lu, Y.L., Chuang, K.H., Hung, W.C., Shiea, J., Su, Y.C., Kao, C.H., Chen, B.M., Roffler, S., and Cheng, T.L. (2008). Tumor-targeting prodrug-activating bacteria for cancer therapy. Cancer Gene Therapy 15, 393-401.
Chevance, F.F.V. and Hughes, K.T. (2008). Coordinating assembly of a bacterial macromolecular machine. Nature Reviews Microbiology 6, 455-465.
Christofori, G. and Semb, H. (1999). The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends in biochemical sciences 24, 73-76.
Chung, A.S., Lee, J., and Ferrara, N. (2010). Targeting the tumour vasculature: insights from physiological angiogenesis. Nat Rev Cancer 10, 505-514.
Clairmont, C., Lee, K.C., Pike, J., Ittensohn, M., Low, K.B., Pawelek, J., Bermudes, D., Brecher, S.M., Margitich, D., Turnier, J., Li, Z., Luo, X., King, I., and Zheng, L.M.
(2000). Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect. Dis. 181, 1996-2002.
Clark, M.A., Jepson, M.A., Simmons, N.L., and Hirst, B.H. (1994). Preferential interaction of Salmonella typhimurium with mouse Peyer's patch M cells. Research in microbiology 145, 543-552.
Clavien,P.A. (1999). Malignant liver tumors. Wiley Online Library).
Cobrinik, D., Dowdy, S.F., Hinds, P.W., Mittnacht, S., and Weinberg, R.A. (1992). The retinoblastoma protein and the regulation of cell cycling. Trends Biochem. Sci. 17, 312-315.
Coley, W.B. (1991). The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clinical orthopaedics and related research 3.
Costerton, J.W., Lewandowski, Z., Caldwell, D.E., Korber, D.R., and Lappin-Scott, H.M. (1995). Microbial biofilms. Annual Reviews in Microbiology 49, 711-745.
Costerton, J.W., Stewart, P.S., and Greenberg, E.P. (1999). Bacterial biofilms: a common cause of persistent infections. Science 284, 1318.
Costerton, W.J. and Wilson, M. (2004). Introducing Biofilms. Biofilms 1, 1-4.
Appendix 106 Counter, C.M., Botelho, F.M., Wang, P., Harley, C.B., and Bacchetti, S. (1994).
Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. Journal of virology 68, 3410.
Coussens, L.M. and Werb, Z. (2002). Inflammation and cancer. Nature 420, 860-867.
Crawford, R.W., Reeve, K.E., and Gunn, J.S. (2010). Flagellated but not hyperfimbriated Salmonella enterica serovar Typhimurium attaches to and forms biofilms on cholesterol-coated surfaces. Journal of bacteriology 192, 2981.
Critchley, R.J., Jezzard, S., Radford, K.J., Goussard, S., Lemoine, N.R., Grillot-Courvalin, C., and Vassaux, G. (2004). Potential therapeutic applications of recombinant, invasive E. coli. Gene therapy 11, 1224-1233.
Dall, P., Herrmann, I., Durst, B., Stoff-Khalili, M.A., Bauerschmitz, G., Hanstein, B., and Niederacher, D. (2005). In vivo cervical cancer growth inhibition by genetically engineered cytotoxic T cells. Cancer Immunology, Immunotherapy 54, 51-60.
Dang, L.H., Bettegowda, C., Huso, D.L., Kinzler, K.W., and Vogelstein, B. (2001).
Combination bacteriolytic therapy for the treatment of experimental tumors. Proceedings of the National Academy of Sciences of the United States of America 98, 15155.
Darji, A., Lage, S., Garbe, A.I., Chakraborty, T., and Weiss, S. (2000). Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier. FEMS Immunology &
Medical Microbiology 27, 341-349.
Darnton, N.C. and Berg, H.C. (2008). Bacterial flagella are firmly anchored. Journal of bacteriology 190, 8223.
De Bock, K., Cauwenberghs, S., and Carmeliet, P. (2011). Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications. Curr. Opin. Genet.
Dev. 21, 73-79.
De Bock, K., De Smet, F., Leite De Oliveira, R., Anthonis, K., and Carmeliet, P. (2009).
Endothelial oxygen sensors regulate tumor vessel abnormalization by instructing phalanx endothelial cells. Journal of Molecular Medicine 87, 561-569.
De Larco, J.E. and Todaro, G.J. (1978). Growth factors from murine sarcoma virus-transformed cells. Proc. Natl Acad. Sci. U. S A 75, 4001-4005.
de Vrij, J., Willemsen, R.A., Lindholm, L., and Hoeben, R.C. (2010). Adenovirus-Derived Vectors for Prostate Cancer Gene Therapy. Human gene therapy 21, 795-805.
DePinho, R.A. (2000). The age of cancer. Nature 408, 248-254.
Di Bisceglie, A.M. (2009). Hepatitis B and hepatocellular carcinoma. Hepatology 49, S56-S60.
Appendix 107 Donlan, R.M. and Costerton, J.W. (2002). Biofilms: survival mechanisms of clinically relevant microorganisms. Clinical microbiology reviews 15, 167.
Druker, B.J. (2008). Translation of the Philadelphia chromosome into therapy for CML.
Blood 112, 4808.
Ermert, D., Urban, C.F., Laube, B., Goosmann, C., Zychlinsky, A., and Brinkmann, V.
(2009). Mouse neutrophil extracellular traps in microbial infections. Journal of innate immunity 1, 181-193.
Escoffre, J.M., Teissie, J., and Rols, M.P. (2010). Gene transfer: how can the biological barriers be overcome? J Membr. Biol 236, 61-74.
Finlay, B.B., Ruschkowski, S., and Dedhar, S. (1991). Cytoskeletal rearrangements accompanying Salmonella entry into epithelial cells. Journal of cell science 99, 283.
Fisher, B., Brown, A., Wolmark, N., Fisher, E.R., Redmond, C., Wickerham, D.L., Margolese, R., Dimitrov, N., Pilch, Y., and Glass, A. (1990). Evaluation of the worth of Corynebacterium parvum in conjunction with chemotherapy as adjuvant treatment for
primary breast cancer: Eight year results from the national surgical adjuvant breast and bowel project B 10. Cancer 66, 220-227.
Forbes, N.S. (2010). Engineering the perfect (bacterial) cancer therapy. Nature Reviews Cancer 10, 785-794.
Forbes, N.S., Munn, L.L., Fukumura, D., and Jain, R.K. (2003). Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors. Cancer Res 63, 5188-5193.
Fritz, E.L. and Van Der Merwe, S.W. (2009). Helicobacter pylori and gastric cancer.
Continuing Medical Education 27, 220.
Galan, J.E. and Curtiss, R. (1989). Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proceedings of the National Academy of Sciences of the United States of America 86, 6383.
Galmbacher, K., Heisig, M., Hotz, C., Wischhusen, J., Galmiche, A., Bergmann, B., Gentschev, I., Goebel, W., Rapp, U.R., and Fensterle, J. (2010). Shigella mediated depletion of macrophages in a murine breast cancer model is associated with tumor regression. PLoS One 5, e9572.
Gamudi, D. and Blundell, R. (2010). Tumor Suppressor Genes. Research Journal of Medical Sciences 4, 280-284.
Ganai, S., Arenas, R.B., and Forbes, N.S. (2009). Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice. Br. J Cancer 101, 1683-1691.
Appendix 109 Hayashi, A., Doi, O., Azuma, I., and Toyoshima, K. (1998). Immuno-friendly use of BCG-cell wall skeleton remarkably improves the survival rate of various cancer patients.
Proceedings of the Japan Academy. Series B Physical and biological sciences 74, 50-55.
Hayflick, L. (1965). The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res.
37, 614-636.
Heimann, D.M. and Rosenberg, S.A. (2003). Continuous intravenous administration of live genetically modified Salmonella typhimurium in patients with metastatic melanoma. Journal of immunotherapy (Hagerstown, Md. : 1997) 26, 179.
Hidaka, A., Hamaji, Y., Sasaki, T., Taniguchi, S., and Fujimori, M. (2007). Exogenous cytosine deaminase gene expression in Bifidobacterium breve I-53-8w for tumor-targeting enzyme/prodrug therapy. Biosci. Biotechnol. Biochem. 71, 2921-2926.
Hoffman, R.M. and Yang, M. (2006). Whole-body imaging with fluorescent proteins.
Nature Protocols 1, 1429-1438.
Iwasaki, A. and Medzhitov, R. (2010). Regulation of adaptive immunity by the innate immune system. Science 327, 291.
Jain, R.K. (2005). Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58.
Janeway Jr, C.A. and Medzhitov, R. (2002). Innate immune recognition. Annual review of immunology 20, 197-216.
Jefferson, K.K. (2004). What drives bacteria to produce a biofilm? FEMS microbiology letters 236, 163-173.
Jepson, M.A. and Clark, M. (2001). The role of M cells in Salmonella infection. Microbes and infection 3, 1183-1190.
Junttila, T.T., Li, G., Parsons, K., Phillips, G.L., and Sliwkowski, M.X. (2010).
Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and
efficiently inhibits growth of lapatinib insensitive breast cancer. Breast Cancer Research and Treatment 1-10.
Kalluri, R. and Zeisberg, M. (2006). Fibroblasts in cancer. Nat Rev Cancer 6, 392-401.
Kasinskas, R.W. and Forbes, N.S. (2006). Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro. Biotechnol. Bioeng. 94, 710-721.
Kessenbrock, K., Plaks, V., and Werb, Z. (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67.
Appendix 110 Kim, S., Takahashi, H., Lin, W.W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J.L., and Karin, M. (2009). Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457, 102-106.
King, I., Bermudes, D., Lin, S., Belcourt, M., Pike, J., Troy, K., Le, T., Ittensohn, M., Mao, J., and Lang, W. (2002). Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent. Human gene therapy 13, 1225-1233.
Kitagawa, A., Fujita, T., Muramatsu, M., Biri, S., and Drentje, A.G. (2010). Review on heavy ion radiotherapy facilities and related ion sources (invited). Review of Scientific Instruments 81, 02B909.
Knox, R.J., Friedlos, F., Jarman, M., and Roberts, J.J. (1988). A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2, 4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells. Biochemical pharmacology 37, 4661-4669.
Kumar, H., Kawai, T., and Akira, S. (2011). Pathogen recognition by the innate immune system. Int. Rev Immunol 30, 16-34.
Lane, D.P. (1992). p53, guardian of the genome. Nature 358, 15-16.
Lee, C.H., Wu, C.L., and Shiau, A.L. (2005a). Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model.
Cancer Gene Ther. 12, 175-184.
Lee, C.H., Wu, C.L., Tai, Y.S., and Shiau, A.L. (2005b). Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy.
Molecular Therapy 11, 707-716.
Leschner, S. and Weiss, S. (2010). Salmonella-allies in the fight against cancer. J Mol. Med.
Leschner, S., Westphal, K., Dietrich, N., Viegas, N., Jablonska, J., Lyszkiewicz, M., Lienenklaus, S., Falk, W., Gekara, N., Loessner, H., and Weiss, S. (2009). Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha. PLoS. One. 4, e6692.
Liu, F.S. (2009). Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review. Taiwanese Journal of Obstetrics and Gynecology 48, 239-244.
Loeb, L.A. (2001). A mutator phenotype in cancer. Cancer research 61, 3230.
Loeb, L.A., Springgate, C.F., and Battula, N. (1974). Errors in DNA replication as a basis of malignant changes. Cancer research 34, 2311.
Appendix 111 Loeffler, M., LeÆNegrate, G., Krajewska, M., and Reed, J.C. (2008). Inhibition of tumor growth using Salmonella expressing Fas ligand. Journal of the National Cancer Institute 100, 1113.
Loessner, H., Endmann, A., Leschner, S., Westphal, K., Rohde, M., Miloud, T., Hammerling, G., Neuhaus, K., and Weiss, S. (2007). Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo. Cell Microbiol 9, 1529-1537.
Low, K.B., Ittensohn, M., Le, T., Platt, J., Sodi, S., Amoss, M., Ash, O., Carmichael, E., Chakraborty, A., Fischer, J., Lin, S.L., Luo, X., Miller, S.I., Zheng, L., King, I., Pawelek, J.M., and Bermudes, D. (1999). Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol. 17, 37-41.
Ludwig, A., Bauer, S., Benz, R., Bergmann, B., and Goebel, W. (1999). Analysis of the SlyA controlled expression, subcellular localization and pore forming activity of a 34 kDa haemolysin (ClyA) from Escherichia coli K 12. Molecular microbiology 31, 557-567.
Luo, J., Solimini, N.L., and Elledge, S.J. (2009). Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136, 823-837.
Macpherson, A. J., Slack, E., Geuking, M. B., and McCoy, K. D. (2009) The mucosal firewalls against commensal intestinal microbes. 31[2], 145-149.
Majewski, I.J. and Bernards, R. (2011). Taming the dragon: genomic biomarkers to individualize the treatment of cancer. Nature medicine 304-312.
Maletzki, C., Linnebacher, M., Kreikemeyer, B., and Emmrich, J. (2008). Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse model. Gut 57, 483.
Malmgren, R.A. and Flanigan, C.C. (1955). Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration. Cancer research 15, 473.
Mantovani, A., Allavena, P., Sica, A., Balkwill, F. (2008). Cancer-related inflammation.
Nature 454. 436-444
Mantovani, A. (2009). Cancer: Inflaming metastasis. Nature 457, 36-37.
Mesnil, M. and Yamasaki, H. (2000). Bystander Effect in Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Cancer Gene Therapy: Role of Gap-junctional Intercellular
Communication1. Cancer research 60, 3989.
Min, J.J., Kim, H.J., Park, J.H., Moon, S., Jeong, J.H., Hong, Y.J., Cho, K.O., Nam, J.H., Kim, N., Park, Y.K., Bom, H.S., Rhee, J.H., and Choy, H.E. (2008a). Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli. Mol. Imaging Biol 10, 54-61.
Appendix 112 Min, J.J., Nguyen, V.H., Kim, H.J., Hong, Y., and Choy, H.E. (2008b). Quantitative
bioluminescence imaging of tumor-targeting bacteria in living animals. Nature Protocols 3, 629-636.
Miura, N., Horikawa, I., Nishimoto, A., Ohmura, H., Ito, H., Hirohashi, S., Shay, J.W., and Oshimura, M. (1997). Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet. Cytogenet. 93, 56-62.
Mkele, G. (2010). Rational selection of cancer chemotherapy. SA Pharmaceutical Journal 77, 32-34.
Monds, R.D. and O'Toole, G.A. (2009). The developmental model of microbial biofilms:
ten years of a paradigm up for review. Trends in microbiology 17, 73-87.
Nemunaitis, J., Cunningham, C., Senzer, N., Kuhn, J., Cramm, J., Litz, C., Cavagnolo, R., Cahill, A., Clairmont, C., and Sznol, M. (2003). Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients. Cancer Gene Therapy 10, 737-744.
Nguyen, V.H., Kim, H.S., Ha, J.M., Hong, Y., Choy, H.E., and Min, J.J. (2010).
Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer. Cancer research 70, 18.
Page, R. and Takimoto, C. (2002). Principles of chemotherapy. Cancer Management: A Multidisciplinary Approach: Medical, Surgical & Radiation Oncology 21.
Papac, R.J. (2001). Origins of cancer therapy. The Yale Journal of Biology and Medicine 74, 391.
Pardee, A.B. and Stein, G.S. (2009). The biology and treatment of cancer.
Patyar, S., Joshi, R., Byrav, D.S.P., Prakash, A., Medhi, B., and Das, B.K. (2010).
Bacteria in cancer therapy: a novel experimental strategy. Journal of biomedical science 17, 1-9.
Pawelek, J.M., Low, K.B., and Bermudes, D. (1997). Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 57, 4537-4544.
Pawelek, J.M., Low, K.B., and Bermudes, D. (2003). Bacteria as tumour-targeting vectors.
Lancet Oncol. 4, 548-556.
Pietras, K. and Ístman, A. (2010). Hallmarks of cancer: interactions with the tumor stroma.
Experimental cell research 316, 1324-1331.
Polk, D.B. and Peek, R.M., Jr. (2010). Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 10, 403-414.
Appendix 113 Powell, S. (2010). Radiotherapy for breast cancer in the 21st Century. Breast J 16 Suppl 1, S34-S38.
Prouty, A.M. and Gunn, J.S. (2003). Comparative analysis of Salmonella enterica serovar Typhimurium biofilm formation on gallstones and on glass. Infection and immunity 71, 7154.
Prouty, A.M., Schwesinger, W.H., and Gunn, J.S. (2002). Biofilm Formation and Interaction with the Surfaces of Gallstones by Salmonella spp. Infection and immunity 70, 2640.
Ramos, H.C., Rumbo, M., and Sirard, J.C. (2004). Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends in microbiology 12, 509-517.
Rosenberg, S.A., Restifo, N.P., Yang, J.C., Morgan, R.A., and Dudley, M.E. (2008).
Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nature Reviews Cancer 8, 299-308.
Rosenberg, S.A., Spiess, P.J., and Kleiner, D.E. (2002). Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium. J Immunother. 25, 218-225.
Ryan, R.M., Green, J., Williams, P.J., Tazzyman, S., Hunt, S., Harmey, J.H., Kehoe, S.C., and Lewis, C.E. (2009). Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors. Gene therapy 16, 329-339.
Sadeghi, M., Enferadi, M., and Shirazi, A. (2010). External and internal radiation therapy:
Past and future directions. Journal of Cancer Research and Therapeutics 6, 239.
Saltzman, D.A., Heise, C.P., Hasz, D.E., Zebede, M., Kelly, S.M., Curtiss III, R.,
Leonard, A.S., and Anderson, P.M. (1996). Attenuated Salmonella typhimurium containing interleukin-2 decreases MC-38 hepatic metastases: a novel anti-tumor agent. Cancer
biotherapy & radiopharmaceuticals 11, 145-153.
Saltzman, D.A., Katsanis, E., Heise, C.P., Hasz, D.E., Vigdorovich, V., Kelly, S.M., Curtiss, R., III, Leonard, A.S., and Anderson, P.M. (1997). Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: a novel antitumor agent? J Pediatr. Surg. 32, 301-306.
Sansonetti, P. (2002). Host-pathogen interactions: the seduction of molecular cross talk. Gut 50, iii2.
Santos, R.L., Zhang, S., Tsolis, R.M., Kingsley, R.A., Garry Adams, L., and Baumler, A.J. (2001). Animal models of Salmonella infections: enteritis versus typhoid fever. Microbes and infection 3, 1335-1344.
Sasaki, T., Fujimori, M., Hamaji, Y., Hama, Y., Ito, K., Amano, J., and Taniguchi, S.
(2006). Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats. Cancer Sci. 97, 649-657.
Appendix 114 Schenk, E., Essand, M., Bangma, C.H., Barber, C., Behr, J.P., Briggs, S., Carlisle, R., Cheng, W.S., Danielsson, A., Dautzenberg, I.J., Dzojic, H., Erbacher, P., Fisher, K., Frazier, A., Georgopoulos, L.J., Hoeben, R., Kochanek, S., Koppers-Lalic, D., Kraaij, R., Kreppel, F., Lindholm, L., Magnusson, M., Maitland, N., Neuberg, P., Nilsson, B., Ogris, M., Remy, J.S., Scaife, M., Schooten, E., Seymour, L., Totterman, T., Uil, T.G., Ulbrich, K., Veldhoven-Zweistra, J.L., de Vrij, J., van Weerden, W., Wagner, E., and Willemsen, R. (2010). Clinical adenoviral gene therapy for prostate cancer. Hum. Gene Ther.
21, 807-813.
Schott, M. (2006). Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers. Endocrine-Related Cancer 13, 779.
Scott, M.T. (1972). Biological effects of the adjuvant Corynebacterium parvum:: I. Inhibition of PHA, mixed lymphocyte and GVH reactivity. Cellular Immunology 5, 459-468.
Sedlacek, H.H., Dickneite, G., and Schorlemmer, H.U. (1986). Chemotherapeutics: A questionable or a promising project. Comparative Immunology, Microbiology and Infectious Diseases 9, 99-119.
Serhan,C.N., Ward,P.A., and Gilroy,D.W. (2010). Fundamentals of inflammation.
Cambridge Univ Pr).
Shea, J.E., Hensel, M., Gleeson, C., and Holden, D.W. (1996). Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proceedings of the National Academy of Sciences of the United States of America 93, 2593.
Shen, H., Kanoh, M., Maruyama, S., Matsumoto, A., Zhang, W., and Asano, Y. (2008).
Attenuated Listeria infection activates natural killer cell cytotoxicity to regress melanoma growth in vivo. Microbiology and immunology 52, 107-117.
Shepherd, F.A., Rodrigues Pereira, J., Ciuleanu, T., Tan, E.H., Hirsh, V., Thongprasert, S., Campos, D., Maoleekoonpiroj, S., Smylie, M., and Martins, R. (2005). Erlotinib in previously treated nonûsmall-cell lung cancer. New England Journal of Medicine 353, 123-132.
Siemann,D.W. (2011). Tumor Microenvironment. Wiley Online Library).
Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A., and McGuire, W.L.
(1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177.
Slamon, D.J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., and Pegram, M. (2001). Use of chemotherapy plus a
monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
New England Journal of Medicine 344, 783-792.
Soghomonyan, S.A., Doubrovin, M., Pike, J., Luo, X., Ittensohn, M., Runyan, J.D., Balatoni, J., Finn, R., Tjuvajev, J.G., and Blasberg, R. (2004). Positron emission
Appendix 116 Theys, J., Nuyts, S., Landuyt, W., Van Mellaert, L., Dillen, C., Bohringer, M., Durre, P., Lambin, P., and Anne, J. (1999). Stable Escherichia coli-Clostridium acetobutylicum shuttle vector for secretion of murine tumor necrosis factor alpha. Applied and environmental
microbiology 65, 4295.
Tjuvajev, J., Blasberg, R., Luo, X., Zheng, L.M., King, I., and Bermudes, D. (2001).
Salmonella-based tumor-targeted cancer therapy: tumor amplified protein expression therapy (TAPET (TM)) for diagnostic imaging. Journal of controlled release 74, 313-315.
Toso, J.F., Gill, V.J., Hwu, P., Marincola, F.M., Restifo, N.P., Schwartzentruber, D.J., Sherry, R.M., Topalian, S.L., Yang, J.C., Stock, F., Freezer, L.J., Morton, K.E., Seipp, C., Haworth, L., Mavroukakis, S., White, D., MacDonald, S., Mao, J., Sznol, M., and Rosenberg, S.A. (2002). Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol. 20, 142-152.
Varner, J.A. and Cheresh, D.A. (1996). Integrins and cancer. Current opinion in cell biology 8, 724-730.
Vergel, M., Marin, J.J., Estevez, P., and Carnero, A. (2011). Cellular Senescence as a Target in Cancer Control. Journal of Aging Research 2011.
Vladimirov, N. and Sourjik, V. (2009). Chemotaxis: how bacteria use memory. Biological Chemistry 390, 1097-1104.
Vogelstein, B. and Kinzler, K.W. (2004). Cancer genes and the pathways they control.
Nature medicine 10, 789-799.
Wang, E., Panelli, M.C., Monsurro, V., and Marincola, F.M. (2004). A global approach to tumor immunology. Cell Mol. Immunol 1, 256-265.
Weibel, S., Stritzker, J., Eck, M., Goebel, W., and Szalay, A.A. (2008). Colonization of experimental murine breast tumours by Escherichia coli K 12 significantly alters the tumour microenvironment. Cellular Microbiology 10, 1235-1248.
Weinberg, R.A. (1995). The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
Weinberg, R.A. (2007). The biology of cancer. Garland Science).
Weinstein, I.B. and Joe, A.K. (2006). Mechanisms of disease: oncogene addictionùa
rationale for molecular targeting in cancer therapy. Nature Clinical Practice Oncology 3, 448-457.
Weiss, S. and Chakraborty, T. (2001). Transfer of eukaryotic expression plasmids to mammalian host cells by bacterial carriers. Current opinion in biotechnology 12, 467-472.
Westphal, K., Leschner, S., Jablonska, J., Loessner, H., and Weiss, S. (2008).
Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res 68, 2952-2960.
Appendix 118 Zogaj, X., Nimtz, M., Rohde, M., Bokranz, W., and Römling, U. (2001). The multicellular morphotypes of Salmonella typhimurium and Escherichia coli produce cellulose as the second component of the extracellular matrix. Molecular microbiology 39, 1452-1463.
zur Hausen, H. (2009). Papillomaviruses in the causation of human cancers--a brief historical account. Virology 384, 260-265.
Appendix 119
3 Own publications
H. Loessner, S. Leschne, A. Endmann, K. Westphal, K. Wolf, K. Kochruebe, T. Miloud, J. Altenbuchner, S. Weiss.
Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice
Microbes and Infection (2009). 11 (14-15):1097-1105 K. Crull, D. Bumann, S. Weiss.
Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium
FEMS Immunology & Medical Microbiology (accepted)
K. Crull, M. Rohde, K. Westphal, H. Loessner, K. Wolf, A. Felipe-López, M. Hensel, S.
Weiss.
Biofilm formation by Salmonella enterica serovar Typhimurium colonizing solid tumors Cellular Microbiology (in revision)
K. Crull, S. Weiss.
Antibiotic control of tumor colonizing Salmonella enterica serovar Typhimurium Experimental Biology and Medicine (submitted)
Appendix 120
4 Curriculum vitae
Katja Crull
Date of birth 03/28/1983
Bolkenhainstraße 1e
Maiden name
Kochrübe 38124 BraunschweigPlace of birth
Lauchhammer Katja.Crull@gmx.deFamily status
married0176 / 23944080
Degree
Dipl.-Biochemist0176 / 23944080